» Articles » PMID: 8440891

A Potential Role for Superantigens in the Pathogenesis of Psoriasis

Overview
Publisher Elsevier
Specialty Dermatology
Date 1993 Mar 1
PMID 8440891
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is a complex inflammatory skin disease in which local vascular changes, T-cell activation, abnormal keratinocyte proliferation and differentiation, and neutrophil activation all contribute to the ongoing disease process. Because of recent interest in T-cell activation as a trigger for psoriatic lesions, we hypothesized that psoriasis may be triggered by superantigens, e.g., toxins of microbial origin that stimulate T cells expressing particular T-cell receptor (TCR) beta chain variable (V beta) gene segments. Lesional skin biopsies and peripheral blood from two patients with acute exacerbations of their psoriasis that appeared to be triggered by infection were analyzed for TCR V beta gene expression using monoclonal antibodies directed against V beta 5.1, 5.2, 6.7, 8.1, and 12. Skin biopsies from both patients demonstrated a different pattern of V beta expansion that correspond to the V beta pattern expected to be induced by the type of superantigen expressed during the infection. In contrast, using immunofluorescence and flow cytometry, peripheral blood T cells from these patients did not demonstrate any expansion of the 5 V beta subsets studied. These observations support the hypothesis that local activation of cutaneous T cells in psoriasis may be caused by a superantigen and provides a new direction for investigating the pathogenesis of this complex and fascinating skin disorder.

Citing Articles

Triggers for the onset and recurrence of psoriasis: a review and update.

Liu S, He M, Jiang J, Duan X, Chai B, Zhang J Cell Commun Signal. 2024; 22(1):108.

PMID: 38347543 PMC: 10860266. DOI: 10.1186/s12964-023-01381-0.


The Use of Microbial Modifying Therapies to Prevent Psoriasis Exacerbation and Associated Cardiovascular Comorbidity.

Reali E, Caliceti C, Lorenzini A, Rizzo P Inflammation. 2023; 47(1):13-29.

PMID: 37953417 PMC: 10799147. DOI: 10.1007/s10753-023-01915-1.


Adiponectin in psoriasis and its comorbidities: a review.

Ruiyang B, Panayi A, Ruifang W, Peng Z, Siqi F Lipids Health Dis. 2021; 20(1):87.

PMID: 34372872 PMC: 8353790. DOI: 10.1186/s12944-021-01510-z.


Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort.

Gonzalez T, Stevens M, Kyzy A, Alarcon R, He H, Kroner J Allergy. 2020; 76(1):302-313.

PMID: 32640045 PMC: 8561741. DOI: 10.1111/all.14489.


Therapeutic Effects of Synthetic Antimicrobial Peptides, TRAIL and NRP1 Blocking Peptides in Psoriatic Keratinocytes.

Ryu S, Broussard L, Youn C, Song B, Norris D, Armstrong C Chonnam Med J. 2019; 55(2):75-85.

PMID: 31161119 PMC: 6536438. DOI: 10.4068/cmj.2019.55.2.75.